Sign In
Buy ADVM
$4.36
+0 (+0%)
At Close: Mar 06, 2026
Is Dexamethasone the Best Treatment for COVID-19? | The Motley Fool
02:24pm, Wednesday, 17'th Jun 2020
A cheap, generically available steroid appears to reduce mortality in patients with the harshest coronavirus cases.
Specsavers: England stores open for routine eye tests from today - what to expect
02:00pm, Wednesday, 17'th Jun 2020
SPECSAVERS has opened its doors in England from today for routine eye and hearing testing. What services is it offering and what will the experience look like?
Cowen & Co. Maintains a Buy Rating on IVERIC bio (ISEE) - Markets
12:47pm, Wednesday, 17'th Jun 2020
Cowen & Co. analyst Ken Cacciatore maintained a Buy rating on IVERIC bio (ISEE – Research Report) on June 15
Scientists to begin human trials next month for Covid-19 treatment derived from cows’ blood
12:07pm, Wednesday, 17'th Jun 2020
A South Dakota company expects to start human trials next month for a Covid-19 antibody treatment derived from the plasma of cows. But these aren’t just any cows. Scientists genetically engin…
Novartis : Cosentyx receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis | MarketScreener
11:32am, Wednesday, 17'th Jun 2020Better Coronavirus Stock: Regeneron or Gilead Sciences? | The Motley Fool
10:38am, Wednesday, 17'th Jun 2020
Both companies feature coronavirus-related work and solid pipelines. One of them may be poised for renewed revenue growth.
Alistan ensayos en humanos de tratamiento para covid-19 derivado de la sangre de las vacas
10:11am, Wednesday, 17'th Jun 2020
Una compañía de Dakota del Sur espera comenzar los ensayos en humanos el próximo mes para un tratamiento de covid-19 con anticuerpos derivados del plasma de vacas.
How to buy Regeneron Pharmaceuticals shares from Australia | 17 Jun price $592.9
08:21am, Wednesday, 17'th Jun 2020
Ever wondered how to buy shares in Regeneron Pharmaceuticals in Australia? We explain how and compare the best share trading platforms.
Massachusetts Financial Services Co. MA Cuts Stake in Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
07:30am, Wednesday, 17'th Jun 2020
Massachusetts Financial Services Co. MA lowered its position in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by 9.9% in the 1st quarter, according to the company in its most recent Form 13F filing with
The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
12:00am, Wednesday, 17'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hour.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 16)
ADC Therapeutics SA (NYSE:...
